HONG KONG--(BUSINESS WIRE)--Biofield Corp. (OTC:BZEC) today reported that the closing documents were executed at the June 16 signing ceremony for the new Chinese national healthcare JV arranged by James MacKay and the MacKay Group -- Worldwide Lifecare Limited (the Carelife JV) -- which will provide Biofield’s Breast Cancer technology and other comprehensive medical technology and services in China.